A new drug delivery system developed by researchers at the University of Hawaiʻi at Mānoa John A. Burns School of Medicine ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

OSE Immunotherapeutics partners with Inside Therapeutics & MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development: Nantes, France Saturday, May 24, 2025, ...

LNP development has been a headache, but without this packaging, mRNA vaccines would be nothing. “It is the unsung hero of the whole thing,” says Giuseppe Ciaramella, who was head of ...

The mRNA platform market holds significant opportunities, driven by advancements in LNP delivery systems, codon optimization, and synthetic biology tools like CRISPR-Cas9. These innovations support ...

New Ventures BC announced that twelve alumni from its annual New Ventures BC (NVBC) Competition will be pitching at Web Summit Vancouver, taking place May 28-30. They'll be competing for a $10,000 ...

OSE Immunotherapeutics. OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies. OSE ...